TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7338174
log Bayes Factor = <0.0001
Chromosome 13   position 51,924,375  (GRCh37) Explore rs7338174 on Ensembl!
Variant rs7338174 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
N18.3 Chronic kidney disease, stage 3
0.000 0.985 0.015
N18 Chronic renal failure
0.000 0.986 0.014
N18.9 Chronic renal failure, unspecified
0.000 0.987 0.013
C56 Malignant neoplasm of ovary
0.013 0.987 0.000
N18.4 Chronic kidney disease, stage 4
0.000 0.988 0.012
K90.0 Coeliac disease
0.011 0.989 0.000
N18.5 Chronic kidney disease, stage 5
0.000 0.989 0.010
N18.8 Other chronic renal failure
0.000 0.990 0.010
N18.1 Chronic kidney disease, stage 1
0.000 0.990 0.010
N18.0 End-stage renal disease
0.000 0.991 0.009
N18.2 Chronic kidney disease, stage 2
0.000 0.991 0.009
D22.5 Melanocytic naevi of trunk
0.008 0.992 0.000
N17-N19 Renal failure
0.000 0.992 0.008
N19 Unspecified renal failure
0.000 0.992 0.008
C43.7 Malignant melanoma of lower limb, including hip
0.008 0.992 0.000
K82.8 Other specified diseases of gallbladder
0.007 0.992 0.000
H25.1 Senile nuclear cataract
0.000 0.993 0.007
K90 Intestinal malabsorption
0.006 0.994 0.000
K90.9 Intestinal malabsorption, unspecified
0.005 0.995 0.000
N17 Acute renal failure
0.000 0.995 0.005
C43 Malignant melanoma of skin
0.005 0.995 0.000
I44.0 Atrioventricular block, first degree
0.005 0.995 0.000
K90.8 Other intestinal malabsorption
0.005 0.995 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.005 0.995 0.000
K90.3 Pancreatic steatorrhoea
0.005 0.995 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.005 0.995 0.000
K90.1 Tropical sprue
0.005 0.995 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.004 0.996 0.000
C43.9 Malignant melanoma of skin, unspecified
0.004 0.996 0.000
I44.7 Left bundle-branch block, unspecified
0.004 0.996 0.000
D22 Melanocytic naevi
0.004 0.996 0.000
N17.8 Other acute renal failure
0.000 0.996 0.004
N17.2 Acute renal failure with medullary necrosis
0.000 0.996 0.004
N17.1 Acute renal failure with acute cortical necrosis
0.000 0.996 0.004
N17.0 Acute renal failure with tubular necrosis
0.000 0.996 0.004
C43.6 Malignant melanoma of upper limb, including shoulder
0.004 0.996 0.000
C51-C58 Malignant neoplasms of female genital organs
0.004 0.996 0.000
C43.4 Malignant melanoma of scalp and neck
0.004 0.996 0.000
D22.6 Melanocytic naevi of upper limb, including shoulder
0.004 0.996 0.000
C43.8 Overlapping malignant melanoma of skin
0.004 0.996 0.000
C43.2 Malignant melanoma of ear and external auricular canal
0.004 0.996 0.000
C43.1 Malignant melanoma of eyelid, including canthus
0.004 0.996 0.000
C43.0 Malignant melanoma of lip
0.004 0.996 0.000
C77.5 Intrapelvic lymph nodes
0.004 0.996 0.000
D05.1 Intraductal carcinoma in situ
0.000 0.996 0.004
C77.9 Lymph node, unspecified
0.004 0.996 0.000
I44 Atrioventricular and left bundle-branch block
0.003 0.997 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.003 0.997 0.000
D22.7 Melanocytic naevi of lower limb, including hip
0.003 0.997 0.000
C77.3 Axillary and upper limb lymph nodes
0.003 0.997 0.000
D22.0 Melanocytic naevi of lip
0.003 0.997 0.000
D22.9 Melanocytic naevi, unspecified
0.003 0.997 0.000
D22.2 Melanocytic naevi of ear and external auricular canal
0.003 0.997 0.000
N63 Unspecified lump in breast
0.000 0.997 0.003
C77.8 Lymph nodes of multiple regions
0.003 0.997 0.000
C43.5 Malignant melanoma of trunk
0.003 0.997 0.000
C77.4 Inguinal and lower limb lymph nodes
0.003 0.997 0.000
C57 Malignant neoplasm of other and unspecified female genital organs
0.003 0.997 0.000
C51 Malignant neoplasm of vulva
0.003 0.997 0.000
C58 Malignant neoplasm of placenta
0.003 0.997 0.000
C55 Malignant neoplasm of uterus, part unspecified
0.003 0.997 0.000
C52 Malignant neoplasm of vagina
0.003 0.997 0.000
D22.4 Melanocytic naevi of scalp and neck
0.003 0.997 0.000
I44.1 Atrioventricular block, second degree
0.003 0.997 0.000
I34.1 Mitral (valve) prolapse
0.003 0.997 0.000
K82 Other diseases of gallbladder
0.003 0.997 0.000
I44.6 Other and unspecified fascicular block
0.003 0.997 0.000
I44.5 Left posterior fascicular block
0.003 0.997 0.000
I44.4 Left anterior fascicular block
0.003 0.997 0.000
C53 Malignant neoplasm of cervix uteri
0.003 0.997 0.000
I34.0 Mitral (valve) insufficiency
0.003 0.997 0.000
I44.3 Other and unspecified atrioventricular block
0.002 0.997 0.000
C77.2 Intra-abdominal lymph nodes
0.003 0.997 0.000
C80 Malignant neoplasm without specification of site
0.002 0.997 0.000
N83.0 Follicular cyst of ovary
0.000 0.997 0.002
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.003 0.997 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.002 0.998 0.000
D22.3 Melanocytic naevi of other and unspecified parts of face
0.002 0.998 0.000
D22.1 Melanocytic naevi of eyelid, including canthus
0.002 0.998 0.000
C51.9 Vulva, unspecified
0.002 0.998 0.000
C51.8 Overlapping lesion of vulva
0.002 0.998 0.000
C51.2 Clitoris
0.002 0.998 0.000
C51.1 Labium minus
0.002 0.998 0.000
C51.0 Labium majus
0.002 0.998 0.000
C57.9 Female genital organ, unspecified
0.002 0.998 0.000
C57.8 Overlapping lesion of female genital organs
0.002 0.998 0.000
C57.7 Other specified female genital organs
0.002 0.998 0.000
C57.4 Uterine adnexa, unspecified
0.002 0.998 0.000
C57.3 Parametrium
0.002 0.998 0.000
C57.2 Round ligament
0.002 0.998 0.000
C57.1 Broad ligament
0.002 0.998 0.000
C57.0 Fallopian tube
0.002 0.998 0.000
K82.2 Perforation of gallbladder
0.002 0.998 0.000
N17.9 Acute renal failure, unspecified
0.000 0.998 0.002
H02.4 Ptosis of eyelid
0.002 0.998 0.000
K86.1 Other chronic pancreatitis
0.002 0.998 0.000
C78.0 Secondary malignant neoplasm of lung
0.002 0.998 0.000
K82.9 Disease of gallbladder, unspecified
0.002 0.998 0.000
I34 Nonrheumatic mitral valve disorders
0.002 0.998 0.000
K82.3 Fistula of gallbladder
0.002 0.998 0.000
K82.0 Obstruction of gallbladder
0.002 0.998 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.002 0.998 0.000
C53.8 Overlapping lesion of cervix uteri
0.002 0.998 0.000
C53.1 Exocervix
0.002 0.998 0.000
C53.0 Endocervix
0.002 0.998 0.000
C80.9 Malignant neoplasm, unspecified
0.002 0.998 0.000
R26.8 Other and unspecified abnormalities of gait and mobility
0.002 0.998 0.000
C54 Malignant neoplasm of corpus uteri
0.002 0.998 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.002 0.998 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.002 0.998 0.000
K76.0 Fatty (change of) liver, not elsewhere classified
0.000 0.998 0.002
N42.8 Other specified disorders of prostate
0.002 0.998 0.000
D05 Carcinoma in situ of breast
0.000 0.998 0.002
E10.1 With ketoacidosis
0.002 0.998 0.000
R19.0 Intra-abdominal and pelvic swelling, mass and lump
0.002 0.998 0.000
I65.0 Occlusion and stenosis of vertebral artery
0.002 0.998 0.000
I44.2 Atrioventricular block, complete
0.002 0.998 0.000
K82.1 Hydrops of gallbladder
0.002 0.998 0.000
C78.7 Secondary malignant neoplasm of liver
0.002 0.998 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.002 0.998 0.000
T78.4 Allergy, unspecified
0.002 0.998 0.000
C34.1 Upper lobe, bronchus or lung
0.000 0.998 0.002
C53.9 Cervix uteri, unspecified
0.002 0.998 0.000
N80.1 Endometriosis of ovary
0.000 0.998 0.002
I34.9 Nonrheumatic mitral valve disorder, unspecified
0.002 0.998 0.000
I34.8 Other nonrheumatic mitral valve disorders
0.002 0.998 0.000
I34.2 Nonrheumatic mitral (valve) stenosis
0.002 0.998 0.000
K76.6 Portal hypertension
0.000 0.998 0.002
N80.0 Endometriosis of uterus
0.000 0.998 0.002
C78.4 Secondary malignant neoplasm of small intestine
0.002 0.998 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.002 0.998 0.000
D05.9 Carcinoma in situ of breast, unspecified
0.000 0.998 0.002
C79 Secondary malignant neoplasm of other sites
0.002 0.998 0.000
C54.9 Corpus uteri, unspecified
0.002 0.998 0.000
C54.8 Overlapping lesion of corpus uteri
0.002 0.998 0.000
C54.3 Fundus uteri
0.002 0.998 0.000
C54.2 Myometrium
0.002 0.998 0.000
C54.0 Isthmus uteri
0.002 0.998 0.000
Y43.3 Other antineoplastic drugs
0.002 0.998 0.000
Z48.8 Other specified surgical follow-up care
0.000 0.998 0.002
R03.0 Elevated blood-pressure reading, without diagnosis of hypertension
0.000 0.998 0.002
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.002 0.998 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.002 0.998 0.000
L40.5 Arthropathic psoriasis
0.002 0.998 0.000
K82.4 Cholesterolosis of gallbladder
0.002 0.998 0.000
N21.0 Calculus in bladder
0.000 0.998 0.002
C79.2 Secondary malignant neoplasm of skin
0.002 0.998 0.000
D05.7 Other carcinoma in situ of breast
0.000 0.998 0.002
D17.5 Benign lipomatous neoplasm of intra-abdominal organs
0.002 0.998 0.000
L40.9 Psoriasis, unspecified
0.002 0.998 0.000
Y44.2 Anticoagulants
0.002 0.998 0.000
Z91.5 Personal history of self-harm
0.000 0.998 0.002
K86.3 Pseudocyst of pancreas
0.002 0.998 0.000
C76.8 Overlapping lesion of other and ill-defined sites
0.002 0.998 0.000
C76.7 Other ill-defined sites
0.002 0.998 0.000
C76.5 Lower limb
0.002 0.998 0.000
C76.4 Upper limb
0.002 0.998 0.000
C76.3 Pelvis
0.002 0.998 0.000
C76.2 Abdomen
0.002 0.998 0.000
C76.1 Thorax
0.002 0.998 0.000
C76.0 Head, face and neck
0.002 0.998 0.000
E10.2 With renal complications
0.002 0.998 0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction
0.002 0.998 0.000
T78.3 Angioneurotic oedema
0.002 0.998 0.000
K86.2 Cyst of pancreas
0.002 0.998 0.000
N20.0 Calculus of kidney
0.000 0.998 0.002
D05.0 Lobular carcinoma in situ
0.000 0.998 0.002
L40.0 Psoriasis vulgaris
0.002 0.998 0.000
T51.0 Ethanol
0.000 0.998 0.002
K86 Other diseases of pancreas
0.002 0.998 0.000
L40 Psoriasis
0.002 0.998 0.000
T78 Adverse effects, not elsewhere classified
0.002 0.998 0.000
E10 Insulin-dependent diabetes mellitus
0.002 0.998 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.001 0.998 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.001 0.998 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.001 0.998 0.000
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
0.002 0.998 0.000
M54.59 Low back pain (Site unspecified)
0.000 0.998 0.002
C79.6 Secondary malignant neoplasm of ovary
0.001 0.998 0.000
T78.1 Other adverse food reactions, not elsewhere classified
0.002 0.998 0.000
N80.3 Endometriosis of pelvic peritoneum
0.000 0.998 0.002
K76 Other diseases of liver
0.000 0.998 0.002
Y44 Agents primarily affecting blood constituents
0.002 0.998 0.000
Y43 Primarily systemic agents
0.002 0.998 0.000
C77.0 Lymph nodes of head, face and neck
0.001 0.998 0.000
E10.9 Without complications
0.002 0.998 0.000
K70.9 Alcoholic liver disease, unspecified
0.000 0.998 0.002
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction
0.002 0.998 0.000
C67.9 Bladder, unspecified
0.000 0.998 0.001
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.001 0.998 0.000
H04.5 Stenosis and insufficiency of lachrymal passages
0.002 0.998 0.000
H11.1 Conjunctival degenerations and deposits
0.001 0.998 0.000
H11.0 Pterygium
0.001 0.998 0.000
I65.2 Occlusion and stenosis of carotid artery
0.001 0.998 0.000
N20.2 Calculus of kidney with calculus of ureter
0.000 0.998 0.001
H11 Other disorders of conjunctiva
0.002 0.998 0.000
N80 Endometriosis
0.000 0.998 0.002
F17.2 Dependence syndrome
0.001 0.998 0.000
H11.9 Disorder of conjunctiva, unspecified
0.001 0.998 0.000
K86.8 Other specified diseases of pancreas
0.001 0.998 0.000
H11.8 Other specified disorders of conjunctiva
0.001 0.999 0.000
L40.8 Other psoriasis
0.001 0.999 0.000
L40.4 Guttate psoriasis
0.001 0.999 0.000
L40.3 Pustulosis palmaris et plantaris
0.001 0.999 0.000
L40.2 Acrodermatitis continua
0.001 0.999 0.000
L40.1 Generalised pustular psoriasis
0.001 0.999 0.000
N13.3 Other and unspecified hydronephrosis
0.000 0.999 0.001
T78.9 Adverse effect, unspecified
0.001 0.999 0.000
T78.8 Other adverse effects, not elsewhere classified
0.001 0.999 0.000
T78.2 Anaphylactic shock, unspecified
0.001 0.999 0.000
T78.0 Anaphylactic shock due to adverse food reaction
0.001 0.999 0.000
C77.1 Intrathoracic lymph nodes
0.001 0.999 0.000
E10.8 With unspecified complications
0.001 0.999 0.000
E10.7 With multiple complications
0.001 0.999 0.000
E10.6 With other specified complications
0.001 0.999 0.000
E10.5 With peripheral circulatory complications
0.001 0.999 0.000
E10.0 With coma
0.001 0.999 0.000
N83.1 Corpus luteum cyst
0.000 0.999 0.001
N88.2 Stricture and stenosis of cervix uteri
0.001 0.999 0.000
R27.0 Ataxia, unspecified
0.001 0.999 0.000
N21 Calculus of lower urinary tract
0.000 0.999 0.001
N20 Calculus of kidney and ureter
0.000 0.999 0.001
R26 Abnormalities of gait and mobility
0.001 0.999 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.001 0.999 0.000
H11.4 Other conjunctival vascular disorders and cysts
0.001 0.999 0.000
Z51.3 Blood transfusion without reported diagnosis
0.001 0.999 0.000
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
0.001 0.999 0.000
J84.1 Other interstitial pulmonary diseases with fibrosis
0.001 0.999 0.000
K70.3 Alcoholic cirrhosis of liver
0.000 0.999 0.001
K76.7 Hepatorenal syndrome
0.000 0.999 0.001
K76.5 Hepatic veno-occlusive disease
0.000 0.999 0.001
K76.4 Peliosis hepatis
0.000 0.999 0.001
K76.3 Infarction of liver
0.000 0.999 0.001
K76.2 Central haemorrhagic necrosis of liver
0.000 0.999 0.001
K76.1 Chronic passive congestion of liver
0.000 0.999 0.001
K86.0 Alcohol-induced chronic pancreatitis
0.001 0.999 0.000
R26.0 Ataxic gait
0.001 0.999 0.000
Y43.9 Primarily systemic agent, unspecified
0.001 0.999 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.001 0.999 0.000
Y43.6 Enzymes, not elsewhere classified
0.001 0.999 0.000
Y43.5 Acidifying and alkalising agents
0.001 0.999 0.000
Y43.2 Antineoplastic natural products
0.001 0.999 0.000
Y43.1 Antineoplastic antimetabolites
0.001 0.999 0.000
Y43.0 Antiallergic and antiemetic drugs
0.001 0.999 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.001 0.999 0.000
Y44.7 Plasma substitutes
0.001 0.999 0.000
Y44.6 Natural blood and blood products
0.001 0.999 0.000
Y44.5 Thrombolytic drugs
0.001 0.999 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.001 0.999 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.001 0.999 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.001 0.999 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.001 0.999 0.000
N80.2 Endometriosis of Fallopian tube
0.000 0.999 0.001
Y57.9 Drug or medicament, unspecified
0.001 0.999 0.000
Y57 Other and unspecified drugs and medicaments
0.001 0.999 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.001 0.999 0.000
S52.60 Fracture of lower end of both ulna and radius (closed)
0.001 0.999 0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery
0.001 0.999 0.000
I65.8 Occlusion and stenosis of other precerebral artery
0.001 0.999 0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries
0.001 0.999 0.000
I65.1 Occlusion and stenosis of basilar artery
0.001 0.999 0.000
C43-C44 Melanoma and other malignant neoplasms of skin
0.001 0.999 0.000
S02.10 Fracture of base of skull (closed)
0.001 0.999 0.000
H11.2 Conjunctival scars
0.001 0.999 0.000
N80.6 Endometriosis in cutaneous scar
0.000 0.999 0.001
N80.5 Endometriosis of intestine
0.000 0.999 0.001
N80.4 Endometriosis of rectovaginal septum and vagina
0.000 0.999 0.001
K70 Alcoholic liver disease
0.000 0.999 0.001
Y49 Psychotropic drugs, not elsewhere classified
0.001 0.999 0.000
M41.96 Scoliosis, unspecified (Lumbar region)
0.001 0.999 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.001 0.999 0.000
Y49.2 Other and unspecified antidepressants
0.001 0.999 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.001 0.999 0.000
E10.4 With neurological complications
0.001 0.999 0.000
Y40.0 Penicillins
0.001 0.999 0.000
Y42.7 Androgens and anabolic congeners
0.001 0.999 0.000
C34 Malignant neoplasm of bronchus and lung
0.000 0.999 0.001
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.001 0.999 0.000
Y40 Systemic antibiotics
0.001 0.999 0.000
I42.9 Cardiomyopathy, unspecified
0.001 0.999 0.000
K86.9 Disease of pancreas, unspecified
0.001 0.999 0.000
N20.9 Urinary calculus, unspecified
0.000 0.999 0.001
N21.9 Calculus of lower urinary tract, unspecified
0.000 0.999 0.001
N21.8 Other lower urinary tract calculus
0.000 0.999 0.001
N21.1 Calculus in urethra
0.000 0.999 0.001
R26.1 Paralytic gait
0.001 0.999 0.000
Y40.3 Macrolides
0.001 0.999 0.000
Y43.4 Immunosuppressive agents
0.001 0.999 0.000
D17.9 Benign lipomatous neoplasm, unspecified
0.001 0.999 0.000
H02.3 Blepharochalasis
0.001 0.999 0.000
I60.8 Other subarachnoid haemorrhage
0.001 0.999 0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery
0.001 0.999 0.000
K70.1 Alcoholic hepatitis
0.000 0.999 0.001
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.001 0.999 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.001 0.999 0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)
0.001 0.999 0.000
E10.3 With ophthalmic complications
0.001 0.999 0.000
H11.3 Conjunctival haemorrhage
0.001 0.999 0.000
N80.8 Other endometriosis
0.000 0.999 0.001
R26.3 Immobility
0.001 0.999 0.000
Y83.2 Surgical operation with anastomosis, bypass or graft
0.000 0.999 0.001
M41.99 Scoliosis, unspecified (Site unspecified)
0.001 0.999 0.000
C34.3 Lower lobe, bronchus or lung
0.000 0.999 0.001
C78.2 Secondary malignant neoplasm of pleura
0.001 0.999 0.000
I25.2 Old myocardial infarction
0.001 0.999 0.000
Y57.8 Other drugs and medicaments
0.001 0.999 0.000
Y57.7 Vitamins, not elsewhere classified
0.001 0.999 0.000
Y57.6 Other diagnostic agents
0.001 0.999 0.000
Y57.5 X-ray contrast media
0.001 0.999 0.000
Y57.4 Pharmaceutical excipients
0.001 0.999 0.000
Y57.3 Alcohol deterrents
0.001 0.999 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.001 0.999 0.000
Y57.1 Lipotropic drugs
0.001 0.999 0.000
Y57.0 Appetite depressants [anorectics]
0.001 0.999 0.000
O48 Prolonged pregnancy
0.000 0.999 0.001
Y59 Other and unspecified vaccines and biological substances
0.001 0.999 0.000
Y58 Bacterial vaccines
0.001 0.999 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.001 0.999 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.001 0.999 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.001 0.999 0.000
Y48 Anaesthetics and therapeutic gases
0.001 0.999 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.001 0.999 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.001 0.999 0.000
S92.00 Fracture of calcaneus (closed)
0.000 0.999 0.001
K70.4 Alcoholic hepatic failure
0.000 0.999 0.001
K70.2 Alcoholic fibrosis and sclerosis of liver
0.000 0.999 0.001
Y49.9 Psychotropic drug, unspecified
0.001 0.999 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.001 0.999 0.000
Y49.7 Psychostimulants with abuse potential
0.001 0.999 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.001 0.999 0.000
Y49.5 Other antipsychotics and neuroleptics
0.001 0.999 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.001 0.999 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.001 0.999 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.001 0.999 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.001 0.999 0.000
C34.8 Overlapping lesion of bronchus and lung
0.000 0.999 0.001
C34.2 Middle lobe, bronchus or lung
0.000 0.999 0.001
C34.0 Main bronchus
0.000 0.999 0.001
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.001 0.999 0.000
I42.0 Dilated cardiomyopathy
0.001 0.999 0.000
M41.9 Scoliosis, unspecified
0.001 0.999 0.000
Y40.8 Other systemic antibiotics
0.001 0.999 0.000
Y40.7 Antifungal antibiotics, systemically used
0.001 0.999 0.000
Y40.6 Rifamycins
0.001 0.999 0.000
Y40.5 Aminoglycosides
0.001 0.999 0.000
Y40.4 Tetracyclines
0.001 0.999 0.000
Y40.2 Chloramphenicol group
0.001 0.999 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.001 0.999 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.001 0.999 0.000
Y41.5 Antiviral drugs
0.001 0.999 0.000
Y41.4 Anthelminthics
0.001 0.999 0.000
Y41.3 Other antiprotozoal drugs
0.001 0.999 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.001 0.999 0.000
Y41.1 Antimycobacterial drugs
0.001 0.999 0.000
Y41.0 Sulphonamides
0.001 0.999 0.000
Y42.9 Other and unspecified hormone antagonists
0.001 0.999 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.001 0.999 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.001 0.999 0.000
Y42.4 Oral contraceptives
0.001 0.999 0.000
Y42.2 Antithyroid drugs
0.001 0.999 0.000
Y42.1 Thyroid hormones and substitutes
0.001 0.999 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.001 0.999 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.001 0.999 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.001 0.999 0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand
0.001 0.999 0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation
0.000 0.999 0.001
Y56.9 Topical agent, unspecified
0.001 0.999 0.000
Y56.8 Other topical agents
0.001 0.999 0.000
Y56.7 Dental drugs, topically applied
0.001 0.999 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.001 0.999 0.000
Y56.5 Ophthalmological drugs and preparations
0.001 0.999 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.001 0.999 0.000
Y56.3 Emollients, demulcents and protectants
0.001 0.999 0.000
Y56.2 Local astringents and local detergents
0.001 0.999 0.000
Y56.1 Antipruritics
0.001 0.999 0.000
M50.2 Other cervical disk displacement
0.001 0.999 0.000
R26.2 Difficulty in walking, not elsewhere classified
0.001 0.999 0.000
Y46.8 Antispasticity drugs
0.001 0.999 0.000
Y46.7 Anti-Parkinsonism drugs
0.001 0.999 0.000
Y46.6 Other and unspecified antiepileptics
0.001 0.999 0.000
Y46.5 Valproic acid
0.001 0.999 0.000
Y46.4 Iminostilbenes
0.001 0.999 0.000
Y46.3 Deoxybarbiturates
0.001 0.999 0.000
Y46.2 Hydantoin derivatives
0.001 0.999 0.000
Y46.1 Oxazolidinediones
0.001 0.999 0.000
Y46.0 Succinimides
0.001 0.999 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.001 0.999 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.001 0.999 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.001 0.999 0.000
Y47.4 Bromine compounds
0.001 0.999 0.000
Y47.3 Paraldehyde
0.001 0.999 0.000
Y47.2 Chloral derivatives
0.001 0.999 0.000
Y47.1 Benzodiazepines
0.001 0.999 0.000
Y47.0 Barbiturates, not elsewhere classified
0.001 0.999 0.000
Y48.5 Therapeutic gases
0.001 0.999 0.000
Y48.4 Anaesthetic, unspecified
0.001 0.999 0.000
Y48.3 Local anaesthetics
0.001 0.999 0.000
Y48.2 Other and unspecified general anaesthetics
0.001 0.999 0.000
Y48.1 Parenteral anaesthetics
0.001 0.999 0.000
Y48.0 Inhaled anaesthetics
0.001 0.999 0.000
Y50.9 Central nervous system stimulant, unspecified
0.001 0.999 0.000
Y50.8 Other central nervous system stimulants
0.001 0.999 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.001 0.999 0.000
Y50.1 Opioid receptor antagonists
0.001 0.999 0.000
Y50.0 Analeptics
0.001 0.999 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.001 0.999 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.001 0.999 0.000
Y53.7 Emetics
0.001 0.999 0.000
Y53.6 Antidiarrhoeal drugs
0.001 0.999 0.000
Y53.5 Digestants
0.001 0.999 0.000
Y53.4 Other laxatives
0.001 0.999 0.000
Y53.3 Saline and osmotic laxatives
0.001 0.999 0.000
Y53.2 Stimulant laxatives
0.001 0.999 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.001 0.999 0.000
Y53.0 Histamine H2-receptor antagonists
0.001 0.999 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.001 0.999 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.001 0.999 0.000
Y55.5 Anticommon cold drugs
0.001 0.999 0.000
Y55.4 Expectorants
0.001 0.999 0.000
Y55.3 Antitussives
0.001 0.999 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.001 0.999 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.001 0.999 0.000
Y55.0 Oxytocic drugs
0.001 0.999 0.000
Y58.9 Other and unspecified bacterial vaccines
0.001 0.999 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.001 0.999 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.001 0.999 0.000
Y58.5 Diphtheria vaccine
0.001 0.999 0.000
Y58.4 Tetanus vaccine
0.001 0.999 0.000
Y58.3 Plague vaccine
0.001 0.999 0.000
Y58.2 Cholera vaccine
0.001 0.999 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.001 0.999 0.000
Y58.0 BCG vaccine
0.001 0.999 0.000
Y59.9 Vaccine or biological substance, unspecified
0.001 0.999 0.000
Y59.8 Other specified vaccines and biological substances
0.001 0.999 0.000
Y59.3 Immunoglobulin
0.001 0.999 0.000
Y59.2 Protozoal vaccines
0.001 0.999 0.000
Y59.1 Rickettsial vaccines
0.001 0.999 0.000
Y59.0 Viral vaccines
0.001 0.999 0.000
D17 Benign lipomatous neoplasm
0.001 0.999 0.000
N75.0 Cyst of Bartholin's gland
0.001 0.999 0.000
Y52 Agents primarily affecting the cardiovascular system
0.001 0.999 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.001 0.999 0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)
0.001 0.999 0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)
0.001 0.999 0.000
M41.94 Scoliosis, unspecified (Thoracic region)
0.001 0.999 0.000
M41.93 Scoliosis, unspecified (Cervicothoracic region)
0.001 0.999 0.000
M41.92 Scoliosis, unspecified (Cervical region)
0.001 0.999 0.000
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)
0.001 0.999 0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)
0.001 0.999 0.000
C16.0 Cardia
0.000 0.999 0.001
H02.1 Ectropion of eyelid
0.001 0.999 0.000
J38.1 Polyp of vocal cord and larynx
0.001 0.999 0.000
K70.0 Alcoholic fatty liver
0.000 0.999 0.001
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.001 0.999 0.000
Y54.9 Mineral salts, not elsewhere classified
0.001 0.999 0.000
Y54.8 Agents affecting uric acid metabolism
0.001 0.999 0.000
Y54.7 Agents affecting calcification
0.001 0.999 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.001 0.999 0.000
Y54.5 Other diuretics
0.001 0.999 0.000
Y54.4 Loop [high-ceiling] diuretics
0.001 0.999 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.001 0.999 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.001 0.999 0.000
Y54.0 Mineralocorticoids
0.001 0.999 0.000
N42 Other disorders of prostate
0.001 0.999 0.000
C16.9 Stomach, unspecified
0.000 0.999 0.001
H04.9 Disorder of lachrymal system, unspecified
0.001 0.999 0.000
H10.9 Conjunctivitis, unspecified
0.001 0.999 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.001 0.999 0.000
D17.4 Benign lipomatous neoplasm of intrathoracic organs
0.001 0.999 0.000
I22.1 Subsequent myocardial infarction of inferior wall
0.001 0.999 0.000
Y54.3 Benzothiadiazine derivatives
0.001 0.999 0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.000 0.999 0.001
N20-N23 Urolithiasis
0.000 0.999 0.001
K76.9 Liver disease, unspecified
0.000 0.999 0.001
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament
0.000 0.999 0.001
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.001 0.999 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.001 0.999 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.001 0.999 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.001 0.999 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.001 0.999 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.001 0.999 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.001 0.999 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.001 0.999 0.000
Y51.0 Anticholinesterase agents
0.001 0.999 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.001 0.999 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.001 0.999 0.000
Y52.7 Peripheral vasodilators
0.001 0.999 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.001 0.999 0.000
Y52.1 Calcium-channel blockers
0.001 0.999 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.001 0.999 0.000
H02 Other disorders of eyelid
0.001 0.999 0.000
C48.1 Specified parts of peritoneum
0.001 0.999 0.000
C54.1 Endometrium
0.001 0.999 0.001
H04.8 Other disorders of lachrymal system
0.001 0.999 0.000
N42.3 Dysplasia of prostate
0.001 0.999 0.000
N42.2 Atrophy of prostate
0.001 0.999 0.000
N42.0 Calculus of prostate
0.001 0.999 0.000
Q54.9 Hypospadias, unspecified
0.001 0.999 0.000
Y40.9 Systemic antibiotic, unspecified
0.001 0.999 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.001 0.999 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.